Literature DB >> 22266534

Oleic acid based heterolipid synthesis, characterization and application in self-microemulsifying drug delivery system.

Rahul S Kalhapure1, Krishnacharya G Akamanchi.   

Abstract

There is increasing demand for lipids owing to their use in formulating lipid based drug delivery systems of poorly soluble drugs. The present work discusses the synthesis, characterization of oleic acid based heterolipid and its use as oil in the development of self-microemulsifying drug delivery system (SMEDDS) for parenteral delivery. Synthesis was carried out by Michael addition of tert-butyl acrylate to 3-amino-1-propanol to obtain di-tert-butyl aminopropanol derivative. Reaction of this di-tert-butyl aminopropanol derivative with oleoyl chloride using p-dimethylaminopyridine as a coupling agent gave the desired heterolipid. It was characterized by (1)H NMR, (13)C NMR and MS to confirm the structure. It did not exhibit any measurable cytotoxicity, even up to 80μg/ml concentration. Application in parenteral drug delivery was explored using furosemide (FUR), a BCS class IV drug, as a model. FUR showed three times greater solubility in the heterolipid as compared to oleic acid. SMEDDSs were developed using heterolipid as oily phase, Solutol HS 15(®) as surfactant and ethanol as a co-surfactant. Developed SMEDDS could form spontaneous microemulsion on addition to various aqueous phases with mean globule size <70nm without any phase separation or drug precipitation even after 24h, and exhibited negligible hemolytic potential.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266534     DOI: 10.1016/j.ijpharm.2012.01.004

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles.

Authors:  Prachi B Shekhawat; Varsha B Pokharkar
Journal:  Acta Pharm Sin B       Date:  2016-11-02       Impact factor: 11.413

2.  Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil.

Authors:  M Biswaranjan Subudhi; Ankit Jain; Ashish Jain; Pooja Hurkat; Satish Shilpi; Arvind Gulbake; Sanjay K Jain
Journal:  Materials (Basel)       Date:  2015-02-27       Impact factor: 3.623

3.  Experimentally Validated QSAR Model for Surface pK a Prediction of Heterolipids Having Potential as Delivery Materials for Nucleic Acid Therapeutics.

Authors:  Dinesh M Dhumal; Pankaj D Patil; Raghavendra V Kulkarni; Krishnacharya G Akamanchi
Journal:  ACS Omega       Date:  2020-11-30

4.  Unexplored Excipients in Biotherapeutic Formulations: Natural Osmolytes as Potential Stabilizers Against Thermally Induced Aggregation of IgG1 Biotherapeutics.

Authors:  Purva P Bhojane; Srishti Joshi; Sushree Jagriti Sahoo; Anurag S Rathore
Journal:  AAPS PharmSciTech       Date:  2021-12-14       Impact factor: 4.026

5.  FSE-Ag complex NS: preparation and evaluation of antibacterial activity.

Authors:  Rahul S Kalhapure; Pradeep Bolla; Delfina C Dominguez; Amit Dahal; Sai H S Boddu; Jwala Renukuntla
Journal:  IET Nanobiotechnol       Date:  2018-09       Impact factor: 1.847

6.  Preparation and Characterization of Novel Perfluorooctyl Bromide Nanoparticle as Ultrasound Contrast Agent via Layer-by-Layer Self-Assembly for Folate-Receptor-Mediated Tumor Imaging.

Authors:  Yue Hu; Yong Wang; Jianshuai Jiang; Baosan Han; Shengmin Zhang; Keshi Li; ShuXiong Ge; Yahui Liu
Journal:  Biomed Res Int       Date:  2016-08-29       Impact factor: 3.411

Review 7.  Microemulgel: an overwhelming approach to improve therapeutic action of drug moiety.

Authors:  Kalpesh C Ashara; Jalpa S Paun; M M Soniwala; J R Chavda; Vishal P Mendapara; Nitin M Mori
Journal:  Saudi Pharm J       Date:  2014-08-09       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.